These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 3706317)
1. Controversies in antimicrobial therapy: formulary decisions on third-generation cephalosporins. Barriere SL Am J Hosp Pharm; 1986 Mar; 43(3):625-9. PubMed ID: 3706317 [TBL] [Abstract][Full Text] [Related]
2. Formulary evaluation of third-generation cephalosporins using decision analysis. Cano SB; Fujita NK Am J Hosp Pharm; 1988 Mar; 45(3):566-9. PubMed ID: 3285673 [TBL] [Abstract][Full Text] [Related]
3. Institution-specific versus published in vitro antimicrobial susceptibility data in making formulary decisions. Franson TR; DaMert GJ; Sheth NK; Wisniewski T; Cooper JE; Johnson R; Babcock JB; Hoffmann RG; Malangoni MA Am J Hosp Pharm; 1987 Jan; 44(1):95-101. PubMed ID: 3826095 [TBL] [Abstract][Full Text] [Related]
4. Application of decision analysis to drug selection for formulary addition. Kresel JJ; Hutchings HC; MacKay DN; Weinstein MC; Read JL; Taylor-Halvorsen K; Ashley H Hosp Formul; 1987 Jul; 22(7):658-63, 673, 676. PubMed ID: 10282682 [TBL] [Abstract][Full Text] [Related]
10. Financial impact of formulary revision of second-generation cephalosporins. Andrews JD; Hafting S Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499 [TBL] [Abstract][Full Text] [Related]
11. A multicenter model for examining in vitro susceptibilities of bacteria to antibiotics. Day D; Mangi R; Jenkins S; Ivey MF Hosp Formul; 1989 Sep; 24(9):513-6, 519-20, 523. PubMed ID: 10294666 [TBL] [Abstract][Full Text] [Related]
12. Cephalosporin-use restrictions in teaching hospitals. McCloskey WW; Johnson PN; Jeffrey LP Am J Hosp Pharm; 1984 Nov; 41(11):2359-62. PubMed ID: 6507437 [TBL] [Abstract][Full Text] [Related]
17. Drug formulary review process for sargramostim and filgrastim: focus on analysis of adverse drug reactions. Kellihan MJ Clin Ther; 1993; 15(5):927-37. PubMed ID: 7505717 [TBL] [Abstract][Full Text] [Related]
18. Cephalosporin selection: view from a beleaguered P & T committee member. Talley JH Hosp Formul; 1986 Jan; 21(1):76-8, 83-4. PubMed ID: 10275082 [TBL] [Abstract][Full Text] [Related]
19. Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital. Rapp RP; Evans ME; Martin C; Ofotokum I; Empey KL; Armitstead JA Curr Med Res Opin; 2004 Apr; 20(4):469-76. PubMed ID: 15119984 [TBL] [Abstract][Full Text] [Related]